US Stock MarketDetailed Quotes

Day One Biopharmaceuticals(Delisted) (DAWN)

Watchlist
  • 21.530
  • 0.0000.00%
Close Apr 22 16:00 ET
2.22BMarket Cap-20.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Day One Biopharmaceuticals(Delisted) (DAWN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
20.60%158.18M
83.92%53.72M
-57.56%39.8M
313.92%33.91M
30.76M
131.16M
29.21M
93.76M
8.19M
0
Operating revenue
20.60%158.18M
83.92%53.72M
-57.56%39.8M
313.92%33.91M
--30.76M
--131.16M
--29.21M
--93.76M
--8.19M
--0
Cost of revenue
226.01%17.21M
103.92%6.08M
181.76%4.48M
432.53%3.77M
2.88M
5.28M
2.98M
1.59M
707K
0
Gross profit
11.99%140.97M
81.64%47.64M
-61.69%35.32M
302.71%30.14M
27.88M
125.88M
26.23M
92.17M
7.49M
0
Operating expense
-21.69%268.72M
-17.98%75.1M
-4.75%59.57M
-46.75%65.12M
3.26%68.94M
66.53%343.15M
53.84%91.56M
21.57%62.54M
148.29%122.29M
45.60%66.77M
Selling and administrative expenses
4.45%120.59M
14.84%34.15M
-2.85%28.15M
-4.03%28.97M
10.42%29.33M
52.83%115.45M
34.13%29.74M
58.53%28.97M
76.82%30.19M
47.32%26.56M
-General and administrative expense
----
----
----
----
10.42%29.33M
----
----
----
----
47.32%26.56M
Research and development costs
-34.94%148.14M
-33.77%40.95M
-6.39%31.42M
-60.75%36.15M
-1.47%39.62M
74.46%227.7M
65.53%61.82M
1.21%33.56M
186.20%92.11M
44.49%40.21M
Operating profit
41.20%-127.75M
57.97%-27.46M
-181.83%-24.25M
69.54%-34.97M
38.49%-41.07M
-5.44%-217.27M
-9.77%-65.33M
157.61%29.64M
-133.09%-114.81M
-45.60%-66.77M
Net non-operating interest income expense
Other net income (expense)
-85.69%18.45M
-30.99%4.2M
-30.59%4.53M
-95.84%4.65M
16.44%5.07M
651.84%128.92M
21.69%6.09M
23.28%6.52M
3,201.45%111.95M
25.79%4.36M
Gain on sale of security
-6.24%18.47M
-31.48%4.15M
-14.34%4.56M
17.90%4.67M
16.70%5.09M
14.63%19.7M
20.46%6.05M
0.59%5.32M
16.32%3.96M
25.94%4.37M
Other non- operating income (expenses)
-100.02%-19K
42.50%57K
-102.84%-34K
-100.02%-19K
-130.00%-23K
273,142.50%109.22M
322.22%40K
40,000.00%1.2M
720,033.33%107.99M
-150.00%-10K
Income before tax
-23.71%-109.3M
60.75%-23.25M
-154.56%-19.73M
-962.07%-30.32M
42.33%-36M
53.23%-88.35M
-8.68%-59.24M
178.34%36.16M
93.77%-2.86M
-47.22%-62.41M
Income tax
-127.66%-1.98M
-130.52%-1.98M
0
0
0
7.14M
6.47M
-882K
1.55M
0
Net income
-12.38%-107.32M
67.62%-21.28M
-153.26%-19.73M
-588.04%-30.32M
42.33%-36M
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
Net income continuous Operations
-12.38%-107.32M
67.62%-21.28M
-153.26%-19.73M
-588.04%-30.32M
42.33%-36M
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
Minority interest income
Net income attributable to the parent company
-12.38%-107.32M
67.62%-21.28M
-153.26%-19.73M
-588.04%-30.32M
42.33%-36M
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.38%-107.32M
67.62%-21.28M
-153.26%-19.73M
-588.04%-30.32M
42.33%-36M
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
Basic earnings per share
-1.96%-1.04
69.57%-0.21
-150.00%-0.19
-480.00%-0.29
51.39%-0.35
56.96%-1.02
-7.81%-0.69
170.37%0.38
91.80%-0.05
-22.03%-0.72
Diluted earnings per share
-1.96%-1.04
69.57%-0.21
-150.00%-0.19
-480.00%-0.29
51.39%-0.35
56.96%-1.02
-7.81%-0.69
170.37%0.38
91.80%-0.05
-22.03%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 20.60%158.18M83.92%53.72M-57.56%39.8M313.92%33.91M30.76M131.16M29.21M93.76M8.19M0
Operating revenue 20.60%158.18M83.92%53.72M-57.56%39.8M313.92%33.91M--30.76M--131.16M--29.21M--93.76M--8.19M--0
Cost of revenue 226.01%17.21M103.92%6.08M181.76%4.48M432.53%3.77M2.88M5.28M2.98M1.59M707K0
Gross profit 11.99%140.97M81.64%47.64M-61.69%35.32M302.71%30.14M27.88M125.88M26.23M92.17M7.49M0
Operating expense -21.69%268.72M-17.98%75.1M-4.75%59.57M-46.75%65.12M3.26%68.94M66.53%343.15M53.84%91.56M21.57%62.54M148.29%122.29M45.60%66.77M
Selling and administrative expenses 4.45%120.59M14.84%34.15M-2.85%28.15M-4.03%28.97M10.42%29.33M52.83%115.45M34.13%29.74M58.53%28.97M76.82%30.19M47.32%26.56M
-General and administrative expense ----------------10.42%29.33M----------------47.32%26.56M
Research and development costs -34.94%148.14M-33.77%40.95M-6.39%31.42M-60.75%36.15M-1.47%39.62M74.46%227.7M65.53%61.82M1.21%33.56M186.20%92.11M44.49%40.21M
Operating profit 41.20%-127.75M57.97%-27.46M-181.83%-24.25M69.54%-34.97M38.49%-41.07M-5.44%-217.27M-9.77%-65.33M157.61%29.64M-133.09%-114.81M-45.60%-66.77M
Net non-operating interest income expense
Other net income (expense) -85.69%18.45M-30.99%4.2M-30.59%4.53M-95.84%4.65M16.44%5.07M651.84%128.92M21.69%6.09M23.28%6.52M3,201.45%111.95M25.79%4.36M
Gain on sale of security -6.24%18.47M-31.48%4.15M-14.34%4.56M17.90%4.67M16.70%5.09M14.63%19.7M20.46%6.05M0.59%5.32M16.32%3.96M25.94%4.37M
Other non- operating income (expenses) -100.02%-19K42.50%57K-102.84%-34K-100.02%-19K-130.00%-23K273,142.50%109.22M322.22%40K40,000.00%1.2M720,033.33%107.99M-150.00%-10K
Income before tax -23.71%-109.3M60.75%-23.25M-154.56%-19.73M-962.07%-30.32M42.33%-36M53.23%-88.35M-8.68%-59.24M178.34%36.16M93.77%-2.86M-47.22%-62.41M
Income tax -127.66%-1.98M-130.52%-1.98M0007.14M6.47M-882K1.55M0
Net income -12.38%-107.32M67.62%-21.28M-153.26%-19.73M-588.04%-30.32M42.33%-36M49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M
Net income continuous Operations -12.38%-107.32M67.62%-21.28M-153.26%-19.73M-588.04%-30.32M42.33%-36M49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M
Minority interest income
Net income attributable to the parent company -12.38%-107.32M67.62%-21.28M-153.26%-19.73M-588.04%-30.32M42.33%-36M49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.38%-107.32M67.62%-21.28M-153.26%-19.73M-588.04%-30.32M42.33%-36M49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M
Basic earnings per share -1.96%-1.0469.57%-0.21-150.00%-0.19-480.00%-0.2951.39%-0.3556.96%-1.02-7.81%-0.69170.37%0.3891.80%-0.05-22.03%-0.72
Diluted earnings per share -1.96%-1.0469.57%-0.21-150.00%-0.19-480.00%-0.2951.39%-0.3556.96%-1.02-7.81%-0.69170.37%0.3891.80%-0.05-22.03%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -